@article {1424808,
	title = {Recurrent corneal erosion syndrome},
	journal = {Br J Ophthalmol},
	volume = {103},
	number = {9},
	year = {2019},
	month = {2019 Sep},
	pages = {1204-1208},
	abstract = {Recurrent corneal erosion syndrome (RCES) is a disorder characterised by a dysfunctional epithelial ecosystem. It often begins after trauma, or in the setting of epithelial basement membrane degeneration or dystrophy. Historically, RCES has been understood as a structural derangement of the anterior corneal architecture. More recently, studies have demonstrated the important role of neuropeptides in corneal homoeostasis. Thus, RCES may also be understood as a disorder of corneal epithelial cell biology. Management of RCES can be challenging, but newer therapies have demonstrated improved efficacy for this condition. This review examines the aetiology and pathogenesis of RCES, and provides an update on current and emerging treatment modalities for the management of this disorder.},
	issn = {1468-2079},
	doi = {10.1136/bjophthalmol-2019-313835},
	author = {Lin, Shawn Rong and Aldave, Anthony J and Chodosh, James}
}
